ALLO Allogene Therapeutics, Inc.
8-K Current Report
Filed: March 12, 2026
Health Care
Biological Products, (No Diagnostic Substances)Allogene Therapeutics, Inc. (ALLO) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results released March 12, 2026
- • Full financial details in Exhibit 99.1 press release — key figures not disclosed in filing body
Get deeper insights on Allogene Therapeutics, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.